Zuclopenthixol dihydrochloride in the management of behavioural disorders in elderly demented patients: A dose‐ranging study

International Journal of Geriatric Psychiatry

Volumn 5, Issue 4, 1990, Pages 265-270

  Venkateswarlu, Tamirisa ^a   Staley, Christopher John ^b   Neal, Charles David ^c  

^a Department of Mental Health for the Elderly ^*  (United Kingdom)

^b St Andrew's Hospital   (United Kingdom)

^c LEIGHTON HOSPITAL   (United Kingdom)

Author keywords

behaviour disorders; dementia; Zuclopenthixol hydrochloride

Indexed keywords

ZUCLOPENTHIXOL;

ADULT; AGE; AGED; ARTICLE; BEHAVIOR; CLINICAL ARTICLE; CONSTIPATION; DEMENTIA; DROWSINESS; HUMAN; INSOMNIA; ORAL DRUG ADMINISTRATION; PSYCHOLOGICAL ASPECT; TREMOR; XEROSTOMIA;

EID: 0025143341     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.930050410     Document Type: Article

References (12)

1. Acute functional psychosis: Treatment with zuclopenthixol dihydrochloride (‘Clopixol’ tablets)
2. A new rating scale for dementia syndromes
3. Cis(z)‐clopenthixol and clopenthixol in the treatment of acute psychosis and exacerbations of chronic psychoses. A doubleblind clinical investigation
4. Drug distribution in old age
5. Cis(z)‐clopenthixol and haloperidol in chronic schizophrenic patients—a double‐blind multicentre investigation
6. A clinical assessment of zuclopenthixol dihydrochloride (‘Clopixol’ tablets) in the treatment of psychotic illness
7. Some problems of clinical trials in elderly patients
8. A new scale for clinical assessment in geriatric population. Sandoz clinical assessment—geriatric (SCAG)
9. Neuroleptics in the treatment of dementia
10. Management of behavioural symptoms in disturbed elderly patients: Comparison of trifluoperazine and haloperidol